ZUG, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) — Following the Company‘s press release published on March 3, the audited consolidated financial statements for the financial year 2025 and the MD&A, which have now been filed with the SEC on form 20-F, are attached.
Attachments
The companies will combine their complementary expertise in synthetic oligosaccharides, conjugation process development and GMP…
BEIJING, June 15, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading…
Poster presentations from ongoing clinical trials of two core assets, olverembatinib and lisaftoclax, highlight global…
This 20,000 sq. ft. facility will redefine fitness standards in Jagatpura, which is the fastest-growing…
THE HAGUE, the Netherlands, June 14, 2026 (GLOBE NEWSWIRE) -- Modat today launched native Passive…
TORONTO, June 14, 2026 (GLOBE NEWSWIRE) -- As participation in online financial markets continues to…